Search research articles
Contact Us
Filters
Showing results (171-180 of 246) with videos related to
Page
of 25
Sort By:
Annals of the Rheumatic Diseases
|
January 4, 2014
TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis
Dominika E Nanus, Andrew D Filer, Beverly Hughes, et al.
RMD Open
|
December 22, 2022
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
Peter C Taylor, Bruno Fautrel, Yves Piette, et al.
Arthritis Research & Therapy
|
March 17, 2021
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis
Kathleen Weisel, Scott Berger, Katie Thorn, et al.
ACR Open Rheumatology
|
December 16, 2021
Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib
Janet E Pope, Yvonne C Lee, Jeffrey R Curtis, et al.
British Journal of Haematology
|
April 27, 2012
Diagnosis and management of acute graft-versus-host disease
Fiona L Dignan, Andrew Clark, Persis Amrolia, et al.
RMD Open
|
March 30, 2018
Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment
Peter C Taylor, Rieke Alten, Juan J Gomez-Reino, et al.
Annals of the Rheumatic Diseases
|
May 3, 2012
Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
Saba Alzabin, Sonya M Abraham, Taher E Taher, et al.
BMJ Open
|
September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Rheumatology (Oxford, England)
|
December 5, 2021
Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis
Line Uhrenholt, Robin Christensen, Wilfred K H Dinesen, et al.
Rheumatology and Therapy
|
October 13, 2024
Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary
Peter C Taylor, Alejandro Balsa, Anne-Barbara Mongey, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 246) with videos related to
Sort By:
Page
of 25
Annals of the Rheumatic Diseases
|
January 4, 2014
TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis
Dominika E Nanus, Andrew D Filer, Beverly Hughes, et al.
RMD Open
|
December 22, 2022
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in Europe
Peter C Taylor, Bruno Fautrel, Yves Piette, et al.
Arthritis Research & Therapy
|
March 17, 2021
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis
Kathleen Weisel, Scott Berger, Katie Thorn, et al.
ACR Open Rheumatology
|
December 16, 2021
Pain Reduction in Rheumatoid Arthritis Patients Who Use Opioids: A Post Hoc Analysis of Phase 3 Trials of Baricitinib
Janet E Pope, Yvonne C Lee, Jeffrey R Curtis, et al.
British Journal of Haematology
|
April 27, 2012
Diagnosis and management of acute graft-versus-host disease
Fiona L Dignan, Andrew Clark, Persis Amrolia, et al.
RMD Open
|
March 30, 2018
Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment
Peter C Taylor, Rieke Alten, Juan J Gomez-Reino, et al.
Annals of the Rheumatic Diseases
|
May 3, 2012
Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
Saba Alzabin, Sonya M Abraham, Taher E Taher, et al.
BMJ Open
|
September 7, 2021
Risk of harm in synthetic and biological intervention trials in patients with inflammatory arthritis: protocol for a metaepidemiological study focusing on contextual factors
Esben Malm, Sabrina Mai Nielsen, Johannes Berg, et al.
Rheumatology (Oxford, England)
|
December 5, 2021
Risk of flare after tapering or withdrawal of biologic/targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis or axial spondyloarthritis: a systematic review and meta-analysis
Line Uhrenholt, Robin Christensen, Wilfred K H Dinesen, et al.
Rheumatology and Therapy
|
October 13, 2024
Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary
Peter C Taylor, Alejandro Balsa, Anne-Barbara Mongey, et al.
Page
of 25